Literature DB >> 4562750

Reducing the number of inferior treatments in clinical trials.

B J Flehinger, T A Louis, H Robbins, B H Singer.   

Abstract

In clinical trials comparing two treatments, one would often like to control the probability of erroneous decision while minimizing not the total sample size but the number of patients given the inferior treatment. To do this obviously requires that one use a datadependent allocation rule for the two treatments rather than the conventional equal sample size scheme, whether fixed or sequential. We show here how this may be done in the case of deciding which of two normally distributed treatment effects has the greater mean, when the variances are assumed to be equal and known. Similar methods can be used under other hypotheses on the underlying probability distributions, and will provide a considerable increase in flexibility in the design of sequential clinical trials.

Entities:  

Mesh:

Year:  1972        PMID: 4562750      PMCID: PMC389692          DOI: 10.1073/pnas.69.10.2993

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  2 in total

1.  Phase II trial design with Bayesian adaptive randomization and predictive probability.

Authors:  Guosheng Yin; Nan Chen; J Jack Lee
Journal:  J R Stat Soc Ser C Appl Stat       Date:  2012-03-01       Impact factor: 1.864

2.  Adaptive Enrichment Designs in Clinical Trials.

Authors:  Peter F Thall
Journal:  Annu Rev Stat Appl       Date:  2021-03       Impact factor: 7.917

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.